More importantly, we provide evidence that pharmacological inhibition of ERK5 may be a promising therapeutic approach to eliminate malignant stem-like cells, avoid chemotherapy resistance, and improve colon cancer treatment. This evidence concerns the gene MAPK7 and malignant colon neoplasm.